BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 2766651)

  • 1. Non random cytogenetic changes characterize Merkel cell carcinoma.
    Koduru PR; Dicostanzo DP; Jhanwar SC
    Dis Markers; 1989; 7(3):153-61. PubMed ID: 2766651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.
    Kardas I; Mrózek K; Babinska M; Krajka K; Hadaczek P; Lubinski J; Roszkiewicz A; Kuziemska E; Limon J
    Oncol Rep; 2005 May; 13(5):949-56. PubMed ID: 15809763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant FHIT transcripts in Merkel cell carcinoma.
    Sozzi G; Alder H; Tornielli S; Corletto V; Baffa R; Veronese ML; Negrini M; Pilotti S; Pierotti MA; Huebner K; Croce CM
    Cancer Res; 1996 Jun; 56(11):2472-4. PubMed ID: 8653678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristic pattern of chromosomal gains and losses in Merkel cell carcinoma detected by comparative genomic hybridization.
    Van Gele M; Speleman F; Vandesompele J; Van Roy N; Leonard JH
    Cancer Res; 1998 Apr; 58(7):1503-8. PubMed ID: 9537255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma.
    Yoshida MA; Ohyashiki K; Ochi H; Gibas Z; Pontes JE; Prout GR; Huben R; Sandberg AA
    Cancer Res; 1986 Apr; 46(4 Pt 2):2139-47. PubMed ID: 3948185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Merkel cell carcinoma with eccrine differentiation: a clinicopathologic study of 7 cases.
    Saeb-Lima M; Montante-Montes de Oca D; Albores-Saavedra J
    Ann Diagn Pathol; 2008 Dec; 12(6):410-4. PubMed ID: 18995205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion mapping of the short arm of chromosome 3 in Merkel cell carcinoma.
    Leonard JH; Williams G; Walters MK; Nancarrow DJ; Rabbitts PH
    Genes Chromosomes Cancer; 1996 Feb; 15(2):102-7. PubMed ID: 8834173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
    Hughson MD; Bigler S; Dickman K; Kovacs G
    Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomes 1, 11, and 13 are frequently involved in karyotypic abnormalities in metastatic Merkel cell carcinoma.
    Leonard JH; Leonard P; Kearsley JH
    Cancer Genet Cytogenet; 1993 May; 67(1):65-70. PubMed ID: 8504402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonrandom chromosome alterations in human malignant mesothelioma.
    Popescu NC; Chahinian AP; DiPaolo JA
    Cancer Res; 1988 Jan; 48(1):142-7. PubMed ID: 3334988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consistent chromosome abnormalities in adenocarcinoma of the pancreas.
    Griffin CA; Hruban RH; Morsberger LA; Ellingham T; Long PP; Jaffee EM; Hauda KM; Bohlander SK; Yeo CJ
    Cancer Res; 1995 Jun; 55(11):2394-9. PubMed ID: 7757992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent differentiation in endocrine and nonendocrine tumors of the skin.
    Foschini MP; Eusebi V
    Semin Diagn Pathol; 2000 May; 17(2):162-8. PubMed ID: 10839616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Merkel cell carcinoma in organ-transplant recipients: report of two cases with unusual histological features and literature review.
    Kanitakis J; Euvrard S; Chouvet B; Butnaru AC; Claudy A
    J Cutan Pathol; 2006 Oct; 33(10):686-94. PubMed ID: 17026521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance.
    Hurr K; Kemp B; Silver SA; el-Naggar AK
    Am J Pathol; 1996 Aug; 149(2):613-20. PubMed ID: 8701999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pax-2 expression in adult renal tumors.
    Daniel L; Lechevallier E; Giorgi R; Sichez H; Zattara-Cannoni H; Figarella-Branger D; Coulange C
    Hum Pathol; 2001 Mar; 32(3):282-7. PubMed ID: 11274636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic alterations in renal tumors: a study of 38 Southeast Asian patients.
    Lau LC; Tan PH; Chong TW; Foo KT; Yip S
    Cancer Genet Cytogenet; 2007 May; 175(1):1-7. PubMed ID: 17498551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas.
    Kovacs G; Frisch S
    Cancer Res; 1989 Feb; 49(3):651-9. PubMed ID: 2910484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent cytogenetic aberrations in human ovarian carcinomas.
    Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
    Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
    Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
    Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.